Non-invasive Brain Trauma Monitoring Device Market Size, Trends and Insights By Product Type (Monitoring Devices, Consumables), By End-User (Hospitals, Neurological Centres, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034
Report Snapshot
Study Period: | 2025-2034 |
Fastest Growing Market: | Europe |
Largest Market: | North America |
Major Players
- Natus Medical Inc.
- Philips Healthcare
- Nihon Kohden Corporation
- GE Healthcare
- Others
Reports Description
Global Non-invasive Brain Trauma Monitoring Device Market was valued at USD 14.98 Billion in 2024 and is expected to reach USD 32.19 Billion by 2034, at a CAGR of 8.13% during the forecast period 2025 – 2034.
Non-invasive Brain Trauma Monitoring Device Market Overview
Non-invasive brain trauma monitoring devices are medical devices used for detection and monitoring functions of brain trauma without surgical procedures. Using sophisticated technologies such as near-infrared spectroscopy (NIRS), electroencephalography (EEG), transcranial Doppler ultrasound, and pupillometry, these devices quantify intracranial pressure, cerebral oxygenation, and brain activity.
They are of vital importance in diagnosing traumatic brain injuries (TBI), strokes, and other neurological conditions. Major end-users are hospitals, ambulatory surgical centers, and diagnostic centers. The growth of the market can be attributed to the increasing cases of TBI, technological advancements, increasing awareness regarding the benefits of non-invasive monitoring, and the increasing adoption of portable and wearable monitoring solutions.
Non-invasive Brain Trauma Monitoring Device Market Growth Factors
Rising Incidence of Traumatic Brain Injuries (TBIs) and Neurological Disorders
The rising incidence of traumatic brain injuries (TBIs) and neurological disorders substantially propels the demand for non-invasive brain trauma monitoring devices. There are about 61,000 deaths from TBI each year in the United States. Such an alarming figure highlights the urgency to implement effective surveillance and diagnostic tools to enable timely interventions to achieve better health outcomes.
These trends are mirrored in the estimated number of new brain cancer cases, which is expected to increase from 24,810 in 2023 to 25,400 in 2024. Additionally, the rising number of TBIs and neurological disorders is linked to the rising number of sports injuries, road accidents, aging populations, etc.
As the occurrence of such health disorders is increasing, the need for innovative non-invasive monitoring alternatives continues to grow, which can supervise brain function without surgery, therefore boosting market growth.
Technological Advancements in Non-Invasive Monitoring Solutions
The global non-invasive brain trauma monitoring devices market is driven by technological innovations. Wearable sensors, portable electroencephalography (EEG), and near-infrared spectroscopy (NIRS) have opened the market early on through more convenient and real-time monitoring solutions.
For instance, in May 2024, Canon Medical Systems launched the Aquilion Serve SP CT scanner in the U.S., integrated with an artificial intelligence (AI)-powered workflow automation system intended to improve imaging and patient care. Such technological advancements permit monitoring of key brain function in real-time, allowing for early detection and intervention, both of which have been shown to improve outcomes.
The incorporation of AI and machine learning algorithms into these devices improves diagnostic accuracy and predictive analytics, making them indispensable tools in clinical settings. With the ever-evolving technology, prospects are around the corner with more advanced, user-friendly , and cost-effective non-invasive monitoring solutions expected to be developed in a short period, which will, in turn, drive the market.
Non-invasive Brain Trauma Monitoring Device Market Restraints
High Cost of Non-Invasive Brain Trauma Monitoring Devices
The exorbitant prices of non-invasive brain trauma monitoring devices act as a major restraint for the growth of this market due to their high usage in developing economies. High-tech monitoring tools (MRI, EEG, etc.) are expensive and not readily available in more resource-constrained clinical settings.
This financial policy can contribute to the uneven availability and quality of neurological care, as organizations may lack the latest technologies. As a consequence, underfunded regions may lack timely and accurate diagnosis in the clinical workforce, potentially undermining treatment outcomes.
This problem can be solved only if the manufacturers and policymakers have something in their minds to reduce the cost of these devices by doing research and development to come up with the inner workings of cheaper devices, or by introducing subsidy programs that would make them affordable for everyone or providing financial incentives to healthcare providers for adopting these devices.
The market would be able to reach and, more importantly, be able to have a greater impact on a wide patient population by making these technologies economically viable.
Non-invasive Brain Trauma Monitoring Device Market Trends
Growing Demand for Wearable Brain Monitoring Devices
The demand for these devices is accelerating as the necessity for continuous and real-time monitoring of brain activity continues to be relevant. Wearable electroencephalogram (EEG) headsets and smart sensors are expanding into the medical professional and research communities, as they are low-cost, portable, and non-invasive devices. These portable devices enable patients with neurological disorders, from epilepsy to concussions to migraines, to monitor their brain activity at home.
This trend is being accelerated by the growing adoption of remote patient monitoring and telemedicine. With the advancement of technology, wearable devices will become precisely accurate and cost-effective devices, ultimately leading to increased adoption of brain trauma monitoring.
Rising Investments in Neurological Research and Development
The demand for non-invasive brain trauma monitoring devices that help prevent further brain injury is predominantly being driven by the growing investments in neurological research and innovation. To improve patient care and diagnostic accuracy, governments, healthcare organizations, and private investors are investing hundreds of millions of dollars to develop advanced monitoring technologies.
There are also some further research forward-looking projects, such as those on brain-computer interfaces, neuroimaging technologies, and artificial intelligence diagnostics. More funding is also driving the commercialization of next-generation brain monitoring devices that are increasingly sensitive, efficient, and affordable.
This trend is expected to influence market growth positively as it facilitates active technology innovations and boosts the application scope for non-invasive brain monitoring solutions.
Non-invasive Brain Trauma Monitoring Device Market Opportunity
Expansion into Emerging Markets with Growing Healthcare Infrastructure
The non-invasive brain trauma monitoring devices market offers substantial growth potential in emerging markets. Several other factors are strengthening this market segment, including fast economic development of economies in regions like Asia-Pacific, Latin America, and Africa, resulting in better healthcare infrastructure and more healthcare spending.
The Asia-Pacific region is anticipated to grow at a considerable CAGR of 10% in the market, owing to government initiatives and investment in the healthcare sector. Since various nations are enhancing their healthcare models, the need for less invasive, effective medical technologies will increase in the years to come.
Sellers can capitalize on this new opportunity, entering these growing markets with more inexpensive, localized offerings. In-market penetration and expansion may be supported by synergetic partnerships with regional healthcare providers and compliance with local regulatory marks.
However, businesses can significantly broaden the potential customer base and achieve high-impact growth worldwide by surmounting these markets unique problems and capitalizing on the growth opportunities they provide.
Integration of Artificial Intelligence and Machine Learning in Monitoring Devices
There is a major growth opportunity for the market by integrating artificial intelligence (AI) and machine learning (ML) technologies in non-invasive brain trauma monitoring devices. AI and ML can improve the functionality of monitoring devices to offer real-time data analysis, predictive analytics, and personalized patient care.
AI tools can also be used to analyze EEG signals, which show complex patterns of brain activity, providing faster and more accurate results than traditional methods and assisting in the early prediction of brain injuries. This development, in turn, generates efficiencies for these professionals and leads to better patient outcomes through early interventions.
Moreover, the introduction of AI-based automation in monitoring devices enhances human error mitigation and facilitates accessibility through remote monitoring solutions. With the improvement of AI and ML features, smart tracking devices with small decision-making and predictive capabilities are expected to have a huge impact on the market.
Non-invasive Brain Trauma Monitoring Device Market Segmentation Analysis
Based on product type, the global non-invasive brain trauma monitoring device market is segmented by monitoring devices and consumables. In the non-invasive brain trauma monitoring devices market, the monitoring devices segment holds the majority of the share, owing to the high adoption of advanced and modern monitoring technologies in hospitals, neurology clinics, and research institutes.
These include electroencephalography (EEG) systems, intracranial pressure (ICP) monitors, transcranial Doppler (TCD) devices, and near-infrared spectroscopy (NIRS) systems, which allow for continuous assessment of brain activity in real time.
As the incidence of traumatic brain injuries (TBIs), strokes, and neurodegenerative diseases continues to increase, healthcare providers are increasingly turning to non-invasive monitoring technologies for the early diagnosis of patients, continuous patient’ monitoring, and timely interventions.
Although consumables, including electrodes, sensors, and disposable probes, are a critical component of monitoring procedures, they generate a lower revenue share due to low cost per unit and single performance. Although their market is growing gradually, high investment in sophisticated monitoring systems results in market domination by monitoring equipment.
Report Scope
Feature of the Report | Details |
Market Size in 2025 | USD 14.98 Billion |
Projected Market Size in 2034 | USD 32.19 Billion |
Market Size in 2024 | USD 14.73 Billion |
CAGR Growth Rate | 8.13% CAGR |
Base Year | 2024 |
Forecast Period | 2025-2034 |
Key Segment | By Product Type, End-User and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Non-invasive Brain Trauma Monitoring Device Market Regional Analysis
The non-invasive brain trauma monitoring devices market is led by North America, owing to the higher occurrence of traumatic brain injuries (TBIs), strokes, and neurodegenerative disorders observed in individuals, especially seen in the two countries, the United States and Canada.
It is estimated that about 2.8 million TBIs occur per year in the U.S., resulting in 61,000 such deaths annually, according to the Centers for Disease Control and Prevention (CDC). Moreover, as the baby boomer generation ages, conditions such as Alzheimer’s and other neurodegenerative diseases impact approximately 6.7 million Americans, creating a need for continuous monitoring of brain function.
The increasing prevalence of sports-induced concussives, road accidents, and falls among the geriatric population further supports the dominance of the region in the glimmering market. While the government and private enterprises are pouring billions of dollars into neurological research and development.
Building on initiatives like that of the National Institute of Neurological Disorders and Stroke (NINDS) and the so-called BRAIN Initiative, there is increasing interest in developing new kinds of non-invasive brain monitoring technology to improve diagnostic, prognostic, and therapeutic outcomes.
Non-invasive Brain Trauma Monitoring Device Market Recent Developments
- In June 2023, Luciole Medical AG acquired Spiegelberg GmbH & Co. KG, creating the revolutionary solutions for brain monitoring and diagnosis. The company will combine the product portfolios of their complementary companies, creating a leading next-gen electroencephalography device manufacturer by combining the product portfolios, manufacturing skills, and distribution pipeline of the two businesses.
- In May 2024, Canon Medical Systems announced the FIRST installation of the Aquilion Serve SP CT scanner with INSTINX, an AI-enabled workflow automation system, at Steinberg Diagnostic Medical Imaging (SDMI), Las Vegas, NV. The latest-generation imaging system delivers superior imaging quality whilst driving productivity and consistency, setting a new standard for imaging technology. The combination of AI technologies and a reengineered workflow can provide a streamlined experience to simplify the scanning process based on diverse clinical needs.
List of the prominent players in the Non-invasive Brain Trauma Monitoring Device Market:
- Natus Medical Inc.
- Philips Healthcare
- Nihon Kohden Corporation
- GE Healthcare
- CAS Medical Systems Inc. (Edwards Lifesciences Corporation)
- Advanced Brain Monitoring
- Siemens AG
- Medtronic Plc.
- Compumedics Ltd.
- Integra LifeSciences
- Covidien PLC
- Sophysa Ltd.
- Spiegelberg GmbH & Co. KG
- Hitachi Medical Corporation
- NeuroLogica Corp.
- NeuroWave Systems Inc.
- Noraxon U.S.A
- RAUMEDIC AG
- Sense Neuro Diagnostics
- BrainScope Company Inc.
- Others
The Non-invasive Brain Trauma Monitoring Device Market is segmented as follows:
By Product Type
- Monitoring Devices
- Consumables
By End-User
- Hospitals
- Neurological Centres
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Non-invasive Brain Trauma Monitoring Device Market, (2025 – 2035) (USD Billion)
- 2.2 Global Non-invasive Brain Trauma Monitoring Device Market : snapshot
- Chapter 3. Global Non-invasive Brain Trauma Monitoring Device Market – Industry Analysis
- 3.1 Non-invasive Brain Trauma Monitoring Device Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising Incidence of Traumatic Brain Injuries (TBIs) and Neurological Disorders
- 3.2.2 Technological Advancements in Non-Invasive Monitoring Solutions.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porters Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product Type
- 3.7.2 Market attractiveness analysis By End-User
- Chapter 4. Global Non-invasive Brain Trauma Monitoring Device Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Non-invasive Brain Trauma Monitoring Device Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Non-invasive Brain Trauma Monitoring Device Market – Product Type Analysis
- 5.1 Global Non-invasive Brain Trauma Monitoring Device Market overview: By Product Type
- 5.1.1 Global Non-invasive Brain Trauma Monitoring Device Market share, By Product Type, 2024 and 2035
- 5.2 Monitoring Devices
- 5.2.1 Global Non-invasive Brain Trauma Monitoring Device Market by Monitoring Devices, 2025 – 2035 (USD Billion)
- 5.3 Consumables
- 5.3.1 Global Non-invasive Brain Trauma Monitoring Device Market by Consumables, 2025 – 2035 (USD Billion)
- 5.1 Global Non-invasive Brain Trauma Monitoring Device Market overview: By Product Type
- Chapter 6. Global Non-invasive Brain Trauma Monitoring Device Market – End-User Analysis
- 6.1 Global Non-invasive Brain Trauma Monitoring Device Market overview: By End-User
- 6.1.1 Global Non-invasive Brain Trauma Monitoring Device Market share, By End-User, 2024 and 2035
- 6.2 Hospitals
- 6.2.1 Global Non-invasive Brain Trauma Monitoring Device Market by Hospitals, 2025 – 2035 (USD Billion)
- 6.3 Neurological Centres
- 6.3.1 Global Non-invasive Brain Trauma Monitoring Device Market by Neurological Centres, 2025 – 2035 (USD Billion)
- 6.4 Others
- 6.4.1 Global Non-invasive Brain Trauma Monitoring Device Market by Others, 2025 – 2035 (USD Billion)
- 6.1 Global Non-invasive Brain Trauma Monitoring Device Market overview: By End-User
- Chapter 7. Non-invasive Brain Trauma Monitoring Device Market – Regional Analysis
- 7.1 Global Non-invasive Brain Trauma Monitoring Device Market Regional Overview
- 7.2 Global Non-invasive Brain Trauma Monitoring Device Market Share, by Region, 2024 & 2035 (USD Billion)
- 7.3. North America
- 7.3.1 North America Non-invasive Brain Trauma Monitoring Device Market, 2025 – 2035 (USD Billion)
- 7.3.1.1 North America Non-invasive Brain Trauma Monitoring Device Market, by Country, 2025 – 2035 (USD Billion)
- 7.3.1 North America Non-invasive Brain Trauma Monitoring Device Market, 2025 – 2035 (USD Billion)
- 7.4 North America Non-invasive Brain Trauma Monitoring Device Market, by Product Type, 2025 – 2035
- 7.4.1 North America Non-invasive Brain Trauma Monitoring Device Market, by Product Type, 2025 – 2035 (USD Billion)
- 7.5 North America Non-invasive Brain Trauma Monitoring Device Market, by End-User, 2025 – 2035
- 7.5.1 North America Non-invasive Brain Trauma Monitoring Device Market, by End-User, 2025 – 2035 (USD Billion)
- 7.6. Europe
- 7.6.1 Europe Non-invasive Brain Trauma Monitoring Device Market, 2025 – 2035 (USD Billion)
- 7.6.1.1 Europe Non-invasive Brain Trauma Monitoring Device Market, by Country, 2025 – 2035 (USD Billion)
- 7.6.1 Europe Non-invasive Brain Trauma Monitoring Device Market, 2025 – 2035 (USD Billion)
- 7.7 Europe Non-invasive Brain Trauma Monitoring Device Market, by Product Type, 2025 – 2035
- 7.7.1 Europe Non-invasive Brain Trauma Monitoring Device Market, by Product Type, 2025 – 2035 (USD Billion)
- 7.8 Europe Non-invasive Brain Trauma Monitoring Device Market, by End-User, 2025 – 2035
- 7.8.1 Europe Non-invasive Brain Trauma Monitoring Device Market, by End-User, 2025 – 2035 (USD Billion)
- 7.9. Asia Pacific
- 7.9.1 Asia Pacific Non-invasive Brain Trauma Monitoring Device Market, 2025 – 2035 (USD Billion)
- 7.9.1.1 Asia Pacific Non-invasive Brain Trauma Monitoring Device Market, by Country, 2025 – 2035 (USD Billion)
- 7.9.1 Asia Pacific Non-invasive Brain Trauma Monitoring Device Market, 2025 – 2035 (USD Billion)
- 7.10 Asia Pacific Non-invasive Brain Trauma Monitoring Device Market, by Product Type, 2025 – 2035
- 7.10.1 Asia Pacific Non-invasive Brain Trauma Monitoring Device Market, by Product Type, 2025 – 2035 (USD Billion)
- 7.11 Asia Pacific Non-invasive Brain Trauma Monitoring Device Market, by End-User, 2025 – 2035
- 7.11.1 Asia Pacific Non-invasive Brain Trauma Monitoring Device Market, by End-User, 2025 – 2035 (USD Billion)
- 7.12. Latin America
- 7.12.1 Latin America Non-invasive Brain Trauma Monitoring Device Market, 2025 – 2035 (USD Billion)
- 7.12.1.1 Latin America Non-invasive Brain Trauma Monitoring Device Market, by Country, 2025 – 2035 (USD Billion)
- 7.12.1 Latin America Non-invasive Brain Trauma Monitoring Device Market, 2025 – 2035 (USD Billion)
- 7.13 Latin America Non-invasive Brain Trauma Monitoring Device Market, by Product Type, 2025 – 2035
- 7.13.1 Latin America Non-invasive Brain Trauma Monitoring Device Market, by Product Type, 2025 – 2035 (USD Billion)
- 7.14 Latin America Non-invasive Brain Trauma Monitoring Device Market, by End-User, 2025 – 2035
- 7.14.1 Latin America Non-invasive Brain Trauma Monitoring Device Market, by End-User, 2025 – 2035 (USD Billion)
- 7.15. The Middle-East and Africa
- 7.15.1 The Middle-East and Africa Non-invasive Brain Trauma Monitoring Device Market, 2025 – 2035 (USD Billion)
- 7.15.1.1 The Middle-East and Africa Non-invasive Brain Trauma Monitoring Device Market, by Country, 2025 – 2035 (USD Billion)
- 7.15.1 The Middle-East and Africa Non-invasive Brain Trauma Monitoring Device Market, 2025 – 2035 (USD Billion)
- 7.16 The Middle-East and Africa Non-invasive Brain Trauma Monitoring Device Market, by Product Type, 2025 – 2035
- 7.16.1 The Middle-East and Africa Non-invasive Brain Trauma Monitoring Device Market, by Product Type, 2025 – 2035 (USD Billion)
- 7.17 The Middle-East and Africa Non-invasive Brain Trauma Monitoring Device Market, by End-User, 2025 – 2035
- 7.17.1 The Middle-East and Africa Non-invasive Brain Trauma Monitoring Device Market, by End-User, 2025 – 2035 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Natus Medical Inc.
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Philips Healthcare
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Nihon Kohden Corporation
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 GE Healthcare
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 CAS Medical Systems Inc. (Edwards Lifesciences Corporation)
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Advanced Brain Monitoring
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Siemens AG
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Medtronic Plc.
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Compumedics Ltd.
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Integra LifeSciences
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Covidien PLC
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Sophysa Ltd.
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Spiegelberg GmbH & Co. KG
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 Hitachi Medical Corporation
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.15 NeuroLogica Corp.
- 8.15.1 Overview
- 8.15.2 Financials
- 8.15.3 Product Portfolio
- 8.15.4 Business Strategy
- 8.15.5 Recent Developments
- 8.16 NeuroWave Systems Inc.
- 8.16.1 Overview
- 8.16.2 Financials
- 8.16.3 Product Portfolio
- 8.16.4 Business Strategy
- 8.16.5 Recent Developments
- 8.17 Noraxon U.S.A
- 8.17.1 Overview
- 8.17.2 Financials
- 8.17.3 Product Portfolio
- 8.17.4 Business Strategy
- 8.17.5 Recent Developments
- 8.18 RAUMEDIC AG
- 8.18.1 Overview
- 8.18.2 Financials
- 8.18.3 Product Portfolio
- 8.18.4 Business Strategy
- 8.18.5 Recent Developments
- 8.19 Sense Neuro Diagnostics
- 8.19.1 Overview
- 8.19.2 Financials
- 8.19.3 Product Portfolio
- 8.19.4 Business Strategy
- 8.19.5 Recent Developments
- 8.20 BrainScope Company Inc.
- 8.20.1 Overview
- 8.20.2 Financials
- 8.20.3 Product Portfolio
- 8.20.4 Business Strategy
- 8.20.5 Recent Developments
- 8.21 Others.
- 8.21.1 Overview
- 8.21.2 Financials
- 8.21.3 Product Portfolio
- 8.21.4 Business Strategy
- 8.21.5 Recent Developments
- 8.1 Natus Medical Inc.
List Of Figures
Figures No 1 to 19
List Of Tables
Tables No 1 to 52
Prominent Player
- Natus Medical Inc.
- Philips Healthcare
- Nihon Kohden Corporation
- GE Healthcare
- CAS Medical Systems Inc. (Edwards Lifesciences Corporation)
- Advanced Brain Monitoring
- Siemens AG
- Medtronic Plc.
- Compumedics Ltd.
- Integra LifeSciences
- Covidien PLC
- Sophysa Ltd.
- Spiegelberg GmbH & Co. KG
- Hitachi Medical Corporation
- NeuroLogica Corp.
- NeuroWave Systems Inc.
- Noraxon U.S.A
- RAUMEDIC AG
- Sense Neuro Diagnostics
- BrainScope Company Inc.
- Others
FAQs
The key factors driving the Market are Rising Incidence of Traumatic Brain Injuries (TBIs) and Neurological Disorders, Technological Advancements in Non-Invasive Monitoring Solutions.
The “Monitoring Devices” category dominated the market in 2024.
The key players in the market are Natus Medical Inc., Philips Healthcare, Nihon Kohden Corporation, GE Healthcare, CAS Medical Systems Inc. (Edwards Lifesciences Corporation), Advanced Brain Monitoring, Siemens AG, Medtronic Plc., Compumedics Ltd., Integra LifeSciences, Covidien PLC, Sophysa Ltd., Spiegelberg GmbH & Co. KG, Hitachi Medical Corporation, NeuroLogica Corp., NeuroWave Systems Inc., Noraxon U.S.A, RAUMEDIC AG, Sense Neuro Diagnostics, BrainScope Company Inc., Others.
“North America” is expected to dominate the market over the forecast period.
The global market is projected to grow at a CAGR of 8.13% during the forecast period, 2025-2034.
The Non-invasive Brain Trauma Monitoring Device Market size was valued at USD 14.98 Billion in 2025.